Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects

Overview of attention for article published in Experimental Hematology & Oncology, April 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#2 of 329)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 32 news outlets
twitter: 1 X user

patent: 3 patents

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 54 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 54 followers.

#HemaMax (rhIL12) safety & hematopoietic & immune effects demonstrated in the clinic http://t.co/aCuF9mIrFy #biotech #natlprep #publichealth

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.